These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1730743)

  • 1. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
    Wu SP; Theodorescu D; Kerbel RS; Willson JK; Mulder KM; Humphrey LE; Brattain MG
    J Cell Biol; 1992 Jan; 116(1):187-96. PubMed ID: 1730743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu mice.
    Hoefer M; Anderer FA
    Cancer Immunol Immunother; 1995 Nov; 41(5):302-8. PubMed ID: 8536276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells.
    Medina-Echeverz J; Vasquez M; Gomar C; Ardaiz N; Berraondo P
    Cancer Immunol Immunother; 2015 Jun; 64(6):717-25. PubMed ID: 25795134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).
    Ye S; Liu Y; Fuller AM; Katti R; Ciotti GE; Chor S; Alam MZ; Devalaraja S; Lorent K; Weber K; Haldar M; Pack MA; Eisinger-Mathason TSK
    Mol Cancer Res; 2020 Apr; 18(4):560-573. PubMed ID: 31988250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel and differentially expressed MicroRNAs in goat enzootic nasal adenocarcinoma.
    Wang B; Ye N; Cao SJ; Wen XT; Huang Y; Yan QG
    BMC Genomics; 2016 Nov; 17(1):896. PubMed ID: 27825300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.
    Principe DR; DeCant B; Staudacher J; Vitello D; Mangan RJ; Wayne EA; Mascariñas E; Diaz AM; Bauer J; McKinney RD; Khazaie K; Pasche B; Dawson DW; Munshi HG; Grippo PJ; Jung B
    Oncotarget; 2017 Jan; 8(3):3826-3839. PubMed ID: 27270652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.
    Morikawa M; Derynck R; Miyazono K
    Cold Spring Harb Perspect Biol; 2016 May; 8(5):. PubMed ID: 27141051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.
    Fink SP; Myeroff LL; Kariv R; Platzer P; Xin B; Mikkola D; Lawrence E; Morris N; Nosrati A; Willson JK; Willis J; Veigl M; Barnholtz-Sloan JS; Wang Z; Markowitz SD
    Oncotarget; 2015 Oct; 6(31):30500-15. PubMed ID: 26437221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.
    Quatromoni JG; Suzuki E; Okusanya O; Judy BF; Bhojnagarwala P; Venegas O; Eruslanov E; Predina JD; Albelda SM; Singhal S
    BMC Immunol; 2013 Jul; 14():30. PubMed ID: 23865808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.
    Geng L; Chaudhuri A; Talmon G; Wisecarver JL; Wang J
    PLoS One; 2013; 8(3):e59918. PubMed ID: 23536895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model.
    Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
    J Exp Clin Cancer Res; 2012 Nov; 31(1):93. PubMed ID: 23151305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.
    Pulipati NR; Jin Q; Liu X; Sun B; Pandey MK; Huber JP; Ding W; Mulder KM
    Int J Cancer; 2011 Aug; 129(3):553-64. PubMed ID: 21469138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.
    Liu XQ; Rajput A; Geng L; Ongchin M; Chaudhuri A; Wang J
    J Biol Chem; 2011 May; 286(18):16082-90. PubMed ID: 21454688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis.
    Yang N; Mahato RI
    Pharm Res; 2011 Apr; 28(4):752-61. PubMed ID: 21347569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice.
    Pandey MK; Liu G; Cooper TK; Mulder KM
    Int J Cancer; 2012 Jan; 130(1):213-22. PubMed ID: 21344377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis.
    Jiang Y; Liu XQ; Rajput A; Geng L; Ongchin M; Zeng Q; Taylor GS; Wang J
    Cancer Res; 2011 Jan; 71(1):234-44. PubMed ID: 21084277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.
    Carvajal CA; Herrada AA; Castillo CR; Contreras FJ; Stehr CB; Mosso LM; Kalergis AM; Fardella CE
    J Endocrinol Invest; 2009 Oct; 32(9):759-65. PubMed ID: 19605974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
    Guo C; Sah JF; Beard L; Willson JK; Markowitz SD; Guda K
    Genes Chromosomes Cancer; 2008 Nov; 47(11):939-46. PubMed ID: 18663744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of transforming growth factor beta and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration.
    Hu H; Milstein M; Bliss JM; Thai M; Malhotra G; Huynh LC; Colicelli J
    Mol Cell Biol; 2008 Mar; 28(5):1573-83. PubMed ID: 18160707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients.
    Angenete E; Langenskiöld M; Palmgren I; Falk P; Oresland T; Ivarsson ML
    Int J Colorectal Dis; 2007 Nov; 22(11):1331-8. PubMed ID: 17657504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.